Open AccessA phase 3, randomized, bouble-blind, active comparator study of the efficacy and safety of bBow015, a biosimilar infliximab, in patients with active rheumatoid arthritis on stable methotrexate doses
Author(s) -
Arvind Chopra,
Jonathan Kay,
Michael S. Wyand,
S Chandrashekara,
Avy J. Olakkengil,
Kaushik Bhojani,
Girish Bhatia,
Gaurav Rathi,
Mathew Thomas,
S. Maroli,
Elizabeth Thomson,
Lucy Shneyer
Publication year - 2014
Publication title -
indian journal of rheumatology/indian journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 11
eISSN - 0973-3701
pISSN - 0973-3698
DOI - 10.1016/j.injr.2014.10.040
Subject(s) - medicine , thiopurine methyltransferase , pharmacogenetics , rheumatoid arthritis , azathioprine , odds ratio , inflammatory bowel disease , ulcerative colitis , pharmacology , gastroenterology , adverse effect , methotrexate , genotype , disease , biochemistry , chemistry , gene